Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kushner

Showing results (191-200 of 245) with videos related to

Pageof 25
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 9, 2016
Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II StudyShakeel Modak, Pat Zanzonico, Jorge A Carrasquillo, et al.
Pediatric Blood & Cancer|November 2, 2007
Brain-sparing radiotherapy for neuroblastoma skull metastasesSuzanne L Wolden, Christopher A Barker, Brian H Kushner, et al.
Sarcoma|May 7, 2015
Myeloablative chemotherapy with autologous stem cell transplant for desmoplastic small round cell tumorChristopher J Forlenza, Brian H Kushner, Nancy Kernan, et al.
Journal of Pediatric Surgery|March 16, 2004
The impact of gross total resection on local control and survival in high-risk neuroblastomaMichael P La Quaglia, Brian H Kushner, Wendy Su, et al.
Pediatric Blood & Cancer|March 10, 2010
Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastomaSonal Bhandari, Nai-Kong V Cheung, Brian H Kushner, et al.
Pediatric Blood & Cancer|July 2, 2020
Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastomaLeo Y Luo, Kim Kramer, Nai-Kong V Cheung, et al.
International Journal of Cancer|September 22, 2016
A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastomaBrian H Kushner, Nai-Kong V Cheung, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2020
Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease ProgressionIrene Y Cheung, Nai-Kong V Cheung, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature reviewB H Kushner, N K Cheung, M P LaQuaglia, et al.
International Journal of Cancer|March 20, 2014
Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastomaNai-Kong V Cheung, Irene Y Cheung, Kim Kramer, et al.
Pageof 25

Showing results (191-200 of 245) with videos related to

Sort By:
Pageof 25
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 9, 2016
Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II StudyShakeel Modak, Pat Zanzonico, Jorge A Carrasquillo, et al.
Pediatric Blood & Cancer|November 2, 2007
Brain-sparing radiotherapy for neuroblastoma skull metastasesSuzanne L Wolden, Christopher A Barker, Brian H Kushner, et al.
Sarcoma|May 7, 2015
Myeloablative chemotherapy with autologous stem cell transplant for desmoplastic small round cell tumorChristopher J Forlenza, Brian H Kushner, Nancy Kernan, et al.
Journal of Pediatric Surgery|March 16, 2004
The impact of gross total resection on local control and survival in high-risk neuroblastomaMichael P La Quaglia, Brian H Kushner, Wendy Su, et al.
Pediatric Blood & Cancer|March 10, 2010
Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastomaSonal Bhandari, Nai-Kong V Cheung, Brian H Kushner, et al.
Pediatric Blood & Cancer|July 2, 2020
Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastomaLeo Y Luo, Kim Kramer, Nai-Kong V Cheung, et al.
International Journal of Cancer|September 22, 2016
A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastomaBrian H Kushner, Nai-Kong V Cheung, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2020
Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease ProgressionIrene Y Cheung, Nai-Kong V Cheung, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature reviewB H Kushner, N K Cheung, M P LaQuaglia, et al.
International Journal of Cancer|March 20, 2014
Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastomaNai-Kong V Cheung, Irene Y Cheung, Kim Kramer, et al.
Pageof 25